Long-Term Results of Mitral Valve Repair.

Introduction: Current guidelines state that patients with severe mitral regurgitation should be treated in reference centers with a high reparability rate, low mortality rate, and durable results.

Objective: To analyze our global experience with the treatment of organic mitral regurgitation from various etiologies operated in a single center.

Methods: We evaluated all surgically treated patients with organic mitral regurgitation from 2004-2017.

20 years experience with the Ross operation in middle-aged patients: the autologous principle is still alive.

Objectives: Review our long-term results with the Ross operation in middle-aged patients.

Methods: Between 1995 and 2016, 129 consecutive patients (106 males); mean age (47.2 ± 5.

Long-term results of the Ross operation: an 18-year single institutional experience.

Objectives: The purpose of the study was to assess the 18-year outcome of the Ross operation (RO), with emphasis on survival, reoperations, and late function of the pulmonary autografts (PAs) and the right-sided pulmonary allografts.

Methods: Between May 1995 to July 2013, 414 patients with a mean age (mean ± standard deviation) of 30.8 ± 13.

Aortic valve replacement with the Cardioprotese Premium bovine pericardium bioprosthesis: four-year clinical results.

Objectives: This study reports the initial clinical and echocardiographic results of the Premium bioprosthetic aortic valve up to 4 years of follow-up.

Methods: Between October 2007 and July 2011, 121 consecutive patients were submitted for aortic valve replacement with the Premium bioprosthetic valve. The mean age was 68 ± 9 years and 64 patients were males.